IHF

iShares U.S. Healthcare Providers ETF

Fundamental data last updated:August 12, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Asset Management

Exchange

AMEX

County of HQ

US

Next Earnings Date

Not Scheduled

Business Summary

The iShares U.S. Healthcare Providers ETF seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector.

 


Analyze IHF on TradingView

VALUATION

P/E

N/A

Market Cap ($M USD)

$789.67M

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

N/A

PRICE TO BOOK

N/A

EV / EBITDA

N/A

5-Year Average P/E

Free Cash Flow Yield

N/A

DCF Value

N/A

Graham Number

N/A

Price to FCF

N/A

EV to FCF

N/A

Earnings Yield

N/A

FCF Yield

N/A

DIVIDEND

Yield

N/A

Annual Payout

N/A

Payout Ratio

N/A

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

N/A

Next Year EPS Growth Estimate

N/A

Next Year Revenue Growth Estimate

N/A

Return on Equity (ROE)

N/A

FREE CASH FLOW

Operating Margin

N/A

Debt-to-Equity

N/A

Piotroski F-Score

N/A

Altman Z-Score

N/A

Return on Invested Capital (ROIC)

N/A

Current Ratio

N/A

Quick Ratio

N/A

Net Debt to EBITDA

N/A

Interest Coverage

N/A

Gross Profit margin

N/A

FCF PER SHARE

N/A

REVENUE PER SHARE

N/A

Analyze IHF on TradingView

Gainseekers Quantitative Analysis

Summary

The market’s current valuation of IHF iShares U.S. Healthcare Providers ETF lacks the clarity typically provided by key financial metrics. With no available data on DCF Value or Graham Number, and absent Forward P/E and Earnings Yield, investors are left in the dark about its intrinsic value and growth potential. The lack of an Altman Z-score further obscures its financial safety, leaving risk-averse investors wary. The ETF’s proximity to its 52-week high suggests a potential overextension, raising caution flags for those considering entry at this level. Overall, the absence of critical financial indicators makes it challenging to form a definitive valuation stance.

AI Exposure / Tech Reliance

In the rapidly evolving landscape of AI and technology, the asset management industry, where IHF operates, is poised for significant transformation. While traditional asset managers may face disruption, those that integrate AI-driven analytics and automation could enhance decision-making and operational efficiency. However, the lack of specific data on IHF's tech adoption leaves its adaptability to these shifts uncertain.

The Bull Case

For a value or GARP investor, the allure of IHF might lie in its sector exposure rather than specific financial metrics, given the absence of ROIC, FCF Yield, and Piotroski F-Score data. The healthcare sector's inherent stability and growth potential could be appealing, especially as demographic trends drive demand. Without concrete metrics, investors might speculate on the ETF's ability to capitalize on these macroeconomic tailwinds, banking on the sector's resilience and long-term growth prospects.

The Bear Case

The glaring absence of essential financial metrics is a significant red flag for potential investors. With no Price/Book, Price/Sales, or cash flow data, assessing the ETF's valuation and operational efficiency is nearly impossible. Its proximity to the 52-week high, combined with a lack of earnings visibility, suggests a technically overextended position. This opacity in financial health could deter investors seeking transparency and robust financial performance.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

N/A

Average Analyst Price Target

N/A

Institutional Ownership %

1-Year Beta

0.92

Insider Buying % (6 Mo)

Distance to 52-Week High

2.73%

Distance to 52-Week Low

19.84%

EARNINGS SURPRISE %

N/A

50-DAY SMA

$46.54

200-DAY SMA

$47.48

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.